Table 5. Combined effect sizes of shoulder abduction and CMS were excluded from a single study.
Outcome index | Study | SMD | 95% CI | P (combined effect size) | I2 (%) |
---|---|---|---|---|---|
Shoulder abduction | Naczk A, 2022 | 0.92 | 0.31, 1.53 | 0.003 | 90 |
Beurskens CH, 2007 | 0.97 | 0.34, 1.59 | 0.002 | 91 | |
Huo M, 2024 | 1.18 | 0.62, 1.74 | <0.001 | 86 | |
Kilbreath SL, 2012 | 1.20 | 0.41, 1.80 | 0.002 | 90 | |
Park JH, 2017 | 0.93 | 0.32, 1.55 | 0.003 | 89 | |
Portela AL, 2008① | 1.11 | 0.48, 1.74 | <0.001 | 91 | |
Portela AL, 2008② | 1.09 | 0.46.1, 72 | <0.001 | 91 | |
Guloglu S, 2023① | 0.99 | 0.35, 1.63 | 0.003 | 91 | |
Guloglu S, 2023② | 1.00 | 0.35, 1.64 | 0.002 | 91 | |
Li YP, 2017 | 0.86 | 0.31, 1.40 | 0.002 | 87 | |
Upper limb motor function | Esteban-Simón A, 2024 | 0.87 | 0.46, 1.28 | <0.001 | 94 |
Beurskens CH, 2007 | 0.87 | 0.46, 1.27 | <0.001 | 94 | |
Bloomquist K, 2021 | 0.92 | 0.52, 1.33 | <0.001 | 94 | |
Bruce J, 2021 | 0.94 | 0.57, 1.30 | <0.001 | 90 | |
Lv F, 2015② | 0.89 | 0.47, 1.30 | <0.001 | 94 | |
Lv F, 2015① | 0.86 | 0.45, 1.27 | <0.001 | 94 | |
Klein I, 2021 | 0.90 | 0.48, 1.33 | <0.001 | 94 | |
Ibrahim M, 2017 | 0.94 | 0.54, 1.34 | <0.001 | 93 | |
Mariano KOP, 2015 | 0.90 | 0.49, 1.30 | <0.001 | 94 | |
Portela AL, 2008② | 0.89 | 0.49, 1.30 | <0.001 | 94 | |
Portela AL, 2008① | 0.88 | 0.48, 1.29 | <0.001 | 94 | |
Guloglu S, 2023② | 0.81 | 0.42, 1.20 | <0.001 | 93 | |
Guloglu S, 2023① | 0.83 | 0.43, 1.23 | <0.001 | 93 | |
Sweeney FC, 2019 | 0.71 | 0.38, 1.05 | <0.001 | 90 | |
Sun XY, 2012② | 0.90 | 0.48, 1.31 | <0.001 | 94 | |
Sun XY, 2012① | 0.87 | 0.46, 1.29 | <0.001 | 94 | |
Sun XY, 2020 | 0.88 | 0.47, 1.29 | <0.001 | 94 | |
Li YP, 2017 | 0.86 | 0.45, 1.27 | <0.001 | 94 | |
Wang YL, 2012② | 0.88 | 0.46, 1.30 | <0.001 | 94 | |
Wang YL, 2012① | 0.90 | 0.48, 1.31 | <0.001 | 94 | |
Zhou K, 2019 | 0.80 | 0.42, 1.17 | <0.001 | 91 |
CMS, Constant and Murley score; SMD, standardized mean difference; CI, confidence interval.